Novel non-chemotherapeutic treatment options for relapsed/refractory cutaneous T-cell lymphomas / 中华皮肤科杂志

ABSTRACT

With the advances in research on cutaneous T-cell lymphomas (CTCL), some new strategies, such as traditional targeted drugs, immune checkpoint inhibitors, histone deacetylase inhibitors and allogeneic hematopoietic stem cell transplantation, have emerged and shown favorable efficacy and safety in clinical trials. This review summarizes recent research progress in non-chemotherapeutic drugs for relapsed/refractory cutaneous T-cell lymphomas.